Susan Fletcher

Search results

• Finished

  The L-type calcium channel as a reporter of successful morpholino oligomer therapy in treatment of Duchenne Muscular Dystrophy cardiomyopathy

  Hool, L. (Investigator 01), Fletcher, S. (Investigator 02) & Wilton, S. (Investigator 03)

  NHMRC National Health and Medical Research Council

  1/01/14 → 31/12/16

  Project: Research

• 2011 - Bypassing Mutations in the 5' Region of the Dystrophin Gene by Promoting Alternative Translation Initiation Codons using Antisense Oligonucleotides

  Adkin, C. (Investigator 01), Wilton, S. (Investigator 02) & Fletcher, S. (Investigator 03)

  The University of Western Australia

  1/01/11 → 31/12/11

  Project: Research

• Personalized Exon Skipping Strategies for the Treatment of DMD

  Wilton, S. (Investigator 01), Adkin, C. (Investigator 02), Ohlendieck, K. (Investigator 03) & Fletcher, S. (Investigator 04)

  Treat-NMD

  1/08/10 → 30/09/13

  Project: Research

• Definition of Dystrophin Functional Domains According to Exon Boundaries to Optimise Splice Switching Therapies for DMD

  Wilton, S. (Investigator 01), Fletcher, S. (Investigator 02) & Pinniger, G. (Investigator 03)

  NHMRC National Health and Medical Research Council

  1/01/10 → 31/12/12

  Project: Research

• Antisense Oligomer Induced Splice Switching Therapy In A Mouse Model Of Spinal Muscular Atrophy

  Wilton, S. (Investigator 01), Fletcher, S. (Investigator 02), Burghes, A. (Investigator 03) & Mitrpant, C. (Investigator 04)

  The University of Western Australia

  1/01/10 → 31/12/10

  Project: Research

• Antisense Oligomer Induced Retoraton of SMN Expression as a Therapy for Spinal Muscular Atrophy

  Wilton, S. (Investigator 01), Fletcher, S. (Investigator 02) & Burghes, A. (Investigator 03)

  Association Francaise contre les Myopathies (AFM)

  1/01/10 → 31/12/11

  Project: Research

• Antisense Oligonucleotide Suppression of Non Deletion DMD Causing Mutations

  Wilton, S. (Investigator 01) & Fletcher, S. (Investigator 02)

  National Institutes of Health

  15/04/09 → 14/04/13

  Project: Research

• Refinement of Exon Skipping Strategies to Address Mutations Occurring in Functional Domains of Dystrophin

  Wilton, S. (Chief Investigator) & Fletcher, S. (Chief Investigator)

  Action Duchenne

  1/01/08 → 31/12/10

  Project: Research

• NHMRC Equipment Grant 2007 - Skeletal Muscle Test System

  Pinniger, G. (Chief Investigator), Bakker, T. (Chief Investigator), Laing, N. (Chief Investigator), Grounds, M. (Chief Investigator), Fletcher, S. (Chief Investigator) & Pillow, J. (Chief Investigator)

  NHMRC Equipment Grants

  1/01/08 → 31/12/08

  Project: Research

• System to Measure Single Skeletal Muscle Cell Shortening Under Physiological Conditions

  Bakker, T. (Investigator 01), Laing, N. (Investigator 02), Arthur, P. (Investigator 03), Fournier, P. (Investigator 04), Fletcher, S. (Investigator 05) & Wilton, S. (Investigator 06)

  NHMRC National Health and Medical Research Council

  31/12/07 → 30/12/08

  Project: Research

• Demonstration of Antisense Oligonucleotide induced exon skipping in human muscle - by passing the need for intramuscular injections in DMD patients

  Wilton, S. (Chief Investigator) & Fletcher, S. (Chief Investigator)

  Sundry Grants

  1/01/06 → 31/12/06

  Project: Research

• Antisense Oligonucleotide Induced Exon Skipping as a Treatment for Duchenne Muscular Dystrophy.

  Wilton, S. (Chief Investigator) & Fletcher, S. (Chief Investigator)

  Sundry Grants

  1/01/04 → 31/12/05

  Project: Research

• Therapeutic Induction of Dystrophin Positive 'Revertant' Fibres in the mdx Mouse

  Wilton, S. (Chief Investigator) & Fletcher, S. (Chief Investigator)

  NHMRC Project Grants

  1/01/04 → 31/12/06

  Project: Research

• Antisense Oligonucleotide Suppression of DMD

  Wilton, S. (Chief Investigator) & Fletcher, S. (Chief Investigator)

  National Institute on Aging

  1/01/04 → 31/12/07

  Project: Research

• Reducing the Severity of DMD by Redirected Pre-mRNA Splicing

  Wilton, S. (Chief Investigator) & Fletcher, S. (Chief Investigator)

  Muscular Dystrophy Association of America

  1/01/04 → 31/12/06

  Project: Research

• Overcoming point mutations in the dystrophin gene

  Fletcher, S. (Chief Investigator) & Wilton, S. (Chief Investigator)

  Medical Research Fund of WA

  1/01/01 → 31/12/01

  Project: Research

• Antisense oligonucleotide induced exon skipping as a treatment for Duchenne Muscular Dystrophy

  Wilton, S. (Chief Investigator) & Fletcher, S. (Chief Investigator)

  NHMRC Project Grants

  1/01/01 → 31/12/03

  Project: Research

• Minimising the consequences of point mutations in the dystrophin gene

  Fletcher, S. (Chief Investigator) & Wilton, S. (Chief Investigator)

  Medical Research Fund of WA

  1/01/00 → 31/12/01

  Project: Research

• Experimental gene therapy for the treatment of a model of Duchenne muscular dystrophy

  Wilton, S. (Chief Investigator), Kakulas, B. (Chief Investigator), Fletcher, S. (Chief Investigator) & Howell, J. (Chief Investigator)

  NHMRC Project Grants

  1/01/97 → 31/12/99

  Project: Research
• Curtailed

  Enhanced exon skipping to treat Duchenne muscular dystrophy

  Wilton, S. (Investigator 01), Bellgard, M. (Investigator 02), Fletcher, S. (Investigator 03) & Barrero, R. (Investigator 04)

  NHMRC National Health and Medical Research Council

  1/01/13 → 30/12/15

  Project: Research